Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

prostate-specific antigen

  • You have access
    Optimizing Biopsy Decisions in PI-RADS 3-4 Lesions: Integrating PSA-derived Biomarkers to Reduce Unnecessary Procedures
    JEN-HAO KUO, YIN-CHIEN OU, CHE-YUAN HU, KUAN-YU WU, CHAN-JUNG LIU, ZE-HONG LU, HAU-CHERN JAN, KUN-CHE LIN, YI-CHIA HSIEH, CHIEN-HUI OU and YUH-SHYAN TSAI
    Anticancer Research December 2025, 45 (12) 5709-5720; DOI: https://doi.org/10.21873/anticanres.17904
  • You have access
    Safety and Outcomes of Intraoperative Ventriculoperitoneal Shunt Clamping During Robotic-assisted Radical Prostatectomy: Retrospective Cohort Analysis
    JHE-YUAN HSU, HSIEN-CHE OU, YEN-CHUAN OU, YI-SHENG LIN, LI-HUA HUANG, WEI-CHUN WENG, CHAO-YU HSU and MIN-CHE TUNG
    Anticancer Research March 2025, 45 (3) 1281-1289; DOI: https://doi.org/10.21873/anticanres.17515
  • Open Access
    Predictive Factors for Early Biochemical Recurrence Following Robot-assisted Radical Prostatectomy
    KENSUKE MITSUNARI, HAJIME FUKUSHIMA, HIROKI KURATA, JUNKI HARADA, YUICHIRO NAKAMURA, TOMOHIRO MATSUO, KOJIRO OHBA, YASUSHI MOCHIZUKI and RYOICHI IMAMURA
    Anticancer Research July 2024, 44 (7) 3149-3154; DOI: https://doi.org/10.21873/anticanres.17129
  • You have access
    Angiotensin II Receptor Blockers Cause Changes in Prostate-specific Antigen Levels: A Retrospective Cohort Study
    AYAKO MAEDA-MINAMI, TOMOKI NISHIKAWA, HIDEKI ISHIKAWA, MICHIHIRO MUTOH, YOSHITO MAKISHIMA, YUTAKA MATSUYAMA, KAZUNORI AKIMOTO, YASUNARI MANO and HIROJI UEMURA
    Anticancer Research December 2023, 43 (12) 5629-5636; DOI: https://doi.org/10.21873/anticanres.16766
  • You have access
    Ra-223 and Ethinylestradiol Combination Therapy in Castration-resistant Prostate Cancer
    TAKAFUMI SHIMADA, KOUJI IZUMI, HIROSHI KANO, SUGURU KADOMOTO, TOMOYUKI MAKINO, RENATO NAITO, HIROAKI IWAMOTO, HIROSHI YAEGASHI, YOSHIFUMI KADONO and ATSUSHI MIZOKAMI
    Anticancer Research February 2022, 42 (2) 1065-1071; DOI: https://doi.org/10.21873/anticanres.15568
  • You have access
    Prognostic Significance of 3-Month Prostate-specific Antigen Level Following Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer
    YUJIRO NAGATA, TAKUO MATSUKAWA, IKKO TOMISAKI and NAOHIRO FUJIMOTO
    Anticancer Research February 2022, 42 (2) 1107-1114; DOI: https://doi.org/10.21873/anticanres.15573
  • You have access
    Therapeutic Effect of Ethinylestradiol in Castration-resistant Prostate Cancer
    TAITO NAKANO, YOSHIFUMI KADONO, HIROAKI IWAMOTO, HIROSHI YAEGASHI, MASASHI IIJIMA, SHOHEI KAWAGUCHI, TAKAHIRO NOHARA, KAZUYOSHI SHIGEHARA, KOUJI IZUMI and ATSUSHI MIZOKAMI
    Anticancer Research April 2020, 40 (4) 2291-2296; DOI: https://doi.org/10.21873/anticanres.14194
  • You have access
    Long-term Results of External Beam Radiotherapy for Prostate Cancer with Prostate-specific Antigen of More Than 50 ng/ml and Without Evidence of Lymph Node or Distant Metastasis
    REI UMEZAWA, KOJI INABA, SATOSHI NAKAMURA, AKIHISA WAKITA, HIROYUKI OKAMOTO, SATOSHI SHIMA, KEISUKE TSUCHIDA, TAIRO KASHIHARA, KAZUMA KOBAYASHI, KEN HARADA, KANA TAKAHASHI, NAOYA MURAKAMI, YOSHINORI ITO, HIROSHI IGAKI, KEIICHI JINGU and JUN ITAMI
    Anticancer Research April 2018, 38 (4) 2303-2309;
  • You have access
    Chronic Periodontitis Does Not Impact Serum Levels of Prostate-specific Antigen
    STEPHAN KRUCK, JÖRG HENNENLOTTER, BASTIAN AMEND, MAYA GEIGER, ELITSA FILIPOVA, TIM NEUMANN, VIKTORIA STÜHLER, TINA SCHUBERT, TILMAN TODENHÖFER, STEFFEN RAUSCH, FABIAN HUETTIG, ARNULF STENZL and JENS BEDKE
    Anticancer Research June 2017, 37 (6) 3163-3167;
  • You have access
    Prognostic Impact of Serum Testosterone and Body Mass Index Before Androgen-deprivation Therapy in Metastatic Prostate Cancer
    MASAKI SHIOTA, ARIO TAKEUCHI, MASAAKI SUGIMOTO, EIJI KASHIWAGI, TAKASHI DEJIMA, KEIJIRO KIYOSHIMA, JUNICHI INOKUCHI, KATSUNORI TATSUGAMI and AKIRA YOKOMIZO
    Anticancer Research December 2015, 35 (12) 6925-6932;

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire